An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)
Status:
Completed
Trial end date:
2018-11-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore safety and efficacy of TMC207 administered as part of
a multi-drug regimen for 24 to 48-week treatment in Japanese participants with pulmonary
multi-drug resistant tuberculosis (MDR-TB), and to evaluate pharmacokinetics (PK) of TMC207
and its primary metabolite M2.